Contrarians POV

Pharma lagging in digital…

imagesPOST SUMMARY:  According to McKinsey&Company “unlike successful B2C companies in other industries— which offer mobile solutions, provide personalized product recommendations, and empower customer-service agents with a 360-degree view of the customer—most healthcare providers and payors are lagging, as are pharmaceutical companies and medical-device manufacturers.”  How much monger does pharma need to get the wake-up call? Continue reading »

Pradaxa: What’s a patient to do?

UnknownPOST SUMMARY: As we learn to think like patients one has to wonder just what the hell a patient on the blood thinner Pradaxa wants to do given the new research that indicates the product may not be as safe as they believed. Continue reading »

Is pharma its own worst enemy?

Make sure your worst enemy is not living between your own two earsOne of the questions I get asked and asked again is “why haven’t most pharma companies changes in their approach to DTC and digital marketing?”.  The answer to this is complex, but at its heart most major consulting research has indicated that time and time again pharma is a laggard when it comes to change and hiring people who can really question current thinking when it comes to meeting the needs of consumers of healthcare. Continue reading »

Will DTC marketers always be laggards?

laggardPOST SUMMARY:  Omnicom Media Group, the global media network that oversees more than $50 billion in annual ad spend for clients such as Apple, Starbucks, McDonald’s and Pepsi, is advising its clients to shift as much as 25% of their TV advertising budgets to online video. Will DTC marketers get the word or will we still be bombarded with drug commercials via the evening news? Continue reading »

60 Minutes slaps the drug industry

screenshot_19POST SUMMARY: The current model of the way cancer drugs are prices is unsustaianable and innovation is needed both to develop new drugs and price them in a way that ensures the drug is priced on “the value” it brings to patients. Continue reading »

Another week, more health news

drugcostsSen. Bernie Sanders and U.S. Rep. Elijah E. Cummings on Thursday launched an investigation into soaring generic drug prices. “We are conducting an investigation into the recent staggering price increases for generic drugs used to treat everything from common medical conditions to life-threatening illnesses,” Sanders, chairman of a Senate health care subcommittee, and Cummings, ranking member of the House oversight committee, wrote in letters to 14 pharmaceutical companies. Continue reading »

Share with your friends










Submit